Collectively, these results demonstrate that upregulated hepatic amino acid metabolism represents a major contributor to hyperglycemia in type 2 diabetes, in which CBP/p300 may play a pivotal role (Figure 7Q). This evidence concerns the gene EP300 and type 2 diabetes mellitus.